Siemens sole source of imaging equipment for Fairview

TriMed Staff | | Health Imaging | Screening
Siemens Medical Solutions has inked a five-year agreement with Fairview-University Medical Center in Minneapolis, Minn., the largest of seven hospitals owned by Fairview Health Services, to be its sole provider of imaging technology.

The alliance will allow physicians at Fairview-University Medical Center access to advanced imaging systems from Siemens including MR, CT, angiography, PET/CT, and ultrasound equipment. One of the first systems to be installed will be the biograph 16 PET/CT, Siemens said.

In addition, Siemens will collaborate with the staff on education programs focused on individual imaging modalities. Siemens and Fairview-University Medical Center also are in discussions to develop a service agreement to cover all of the imaging equipment at the facility, Siemens said.

TriMed Staff

Related Content

AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.